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Abstract
Background: Effective strategies are needed to provide screening and treatment for hepatitis B and C to immigrant
groups in the UK at high risk of chronic infection. This study aimed to build an understanding of the knowledge, beliefs
and attitudes towards these conditions and their management in a range of high-risk minority ethnic communities and
health professionals, in order to inform the design of a screening and treatment programme in primary care.
Methods: Qualitative data collection consisted of three sequential phases- (i) semi-structured interviews with key
informants (n = 17), (ii) focus groups with people from Chinese, Pakistani, Roma, Somali, and French- and English-
speaking African communities (n = 95), and (iii) semi-structured interviews with general practitioners (n = 6). Datasets
from each phase were analysed using the Framework method.
Results: Key informants and general practitioners perceived that there was limited knowledge and understanding about
hepatitis B and C within high-risk immigrant communities, and that chronic viral hepatitis did not typically feature in
community discourses about serious illness. Many focus group participants were confused about the differences
between types of viral hepatitis, held misconceptions regarding transmission, and were unaware of the asymptomatic
nature of chronic infection. Most welcomed the idea of a screening programme, but key informants and focus group
participants also identified numerous practical barriers to engagement with primary care-based screening and treatment;
including language and communication difficulties, limited time (due to long working hours), and (for some) low levels
of trust and confidence in general practice-based care. General practitioners expressed concerns about the workload
implications and sustainability of screening and treating immigrant patients for chronic viral hepatitis in primary care.
Conclusions: Strategies to reduce the burden of chronic viral hepatitis in immigrant communities will need to consider
how levels of understanding about hepatitis B and C within these communities, and barriers to accessing healthcare,
may affect capacity to engage with screening and treatment. Services may need to work with community groups and
language support services to provide information and wider encouragement for screening. Primary care services will
need ongoing consultation regarding their support needs to deliver hepatitis screening and treatment programmes.
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Background
The Chief Medical Officer for England and Wales re-
cently highlighted that action is needed to address the
growing burden of liver disease, for which undiagnosed
hepatitis infection is a major contributory factor. [1]
Chronic viral hepatitis, due to either hepatitis B (with or
without delta superinfection) or hepatitis C, is a global
health concern affecting an estimated 500 million people
and causing approximately one million annual deaths,
mostly through liver diseases, including cirrhosis and
cancer [2]. Vaccination is reducing the prevalence of
hepatitis B infection and drugs that control virus replica-
tion and reduce morbidity are available [3], which are
cost effective and recommended by the National Institute
for Health and Care Excellence [4]. Current therapies for
hepatitis C are based on poorly tolerated pegylated inter-
feron, but the development of highly effective all oral re-
gimes [5] provides an opportunity to eliminate the virus
from many regions of the world. However, modelling
studies for hepatitis C have shown that simply providing
effective therapies will not substantially reduce the burden
of disease; [6] increased access to treatment will be needed
to modify the prevalence of cirrhosis and liver cancer. Al-
though similar studies have not been performed for hepa-
titis B infection there is no reason to believe that similar
models will not apply. To impact the global burden of dis-
ease from chronic viral hepatitis it will therefore be im-
portant to improve rates of diagnosis and treatment in
high-risk groups.
Chronic viral hepatitis is common in the developing
world, where transmission is typically by mother to
foetus, or child to child transmission (e.g. hepatitis B in
south-east Asia and sub-Saharan Africa) [7], or by blood
borne transmission through contaminated medical
equipment (e.g. hepatitis C in Egypt, Pakistan and North
Africa) [8,9]. Hepatitis B and C are also moderately preva-
lent in some Eastern European countries, such as Poland,
Romania, the Ukraine and Russia; [10,11] where a variety
of transmission routes operate. High-income countries
have typically had low rates of chronic viral hepatitis, with
infection mostly occurring through sexual transmission in
adults (hepatitis B) or via contaminated drug parapherna-
lia (hepatitis C) [8,12]. However, migration-related chronic
viral hepatitis is an emerging public health issue in high-
income countries [13]. In the UK, studies have identified
significantly higher prevalence rates of hepatitis B and C,
and increased mortality from the outcomes of chronic in-
fection, in minority ethnic communities (including Black
African, Pakistani and Chinese community samples) com-
pared to the white British population [14-17]. Effective
strategies are thus needed to provide hepatitis screening
and treatment programmes to immigrant groups in the
UK at high risk of chronic infection [18]. The success of a
screening programme depends on how well it engages
target groups [19], whose health beliefs and perspectives
are likely to affect acceptance and uptake. Previous re-
search conducted in North America [20,21] and Australia
[22] (with Asian communities) and the Netherlands (with
the Turkish-Dutch community) [23,24] has suggested low
levels of knowledge about hepatitis among high-risk mi-
nority populations, which appears to be an important fac-
tor in whether hepatitis screening is sought. [25] No
research to date has explored lay understandings of hepa-
titis B and C, or attitudes to screening and treatment, in
high-risk immigrant communities in the UK.
In this paper we report the findings of a qualitative
study that explored knowledge, perceptions and folk
models of hepatitis B and C in a number of high-risk im-
migrant communities in the UK. The study also explored
lay and professional perspectives on a proposed model of
targeted screening and treatment provision for hepatitis B
and C within primary care services. Findings were used to
inform a cluster randomised controlled trial of hepatitis
screening and treatment in general practices in London,
Bradford and Oxford- the ‘HepFree’ study- which involves
GP practices sending screening invitation letters to their
patients from at-risk immigrant communities.
Methods
Study design
Our study focused on immigrant communities from four
regions known to be at high risk of hepatitis B and C:
China, Pakistan, Africa and Eastern Europe [2,26]. To
maximise the trade-off between depth and breadth, the
research was conducted with microcosms of each of
these communities in the UK - Pakistani communities in
east London and Bradford, the Chinese community in
central London, Somali and other African communities
in south London, and Eastern European (including
Roma) communities in east London. We worked closely
with community health and advocacy organisations for
the development and implementation of the research.
The study was conducted in three phases: (i) individual
interviews with 17 key informants (approximately four per
community), (ii) 12 focus groups with 95 people from the
target immigrant communities (groups ranged from 6 to
10 participants, with an average group size of 8 people)
(iii) individual interviews with six general practitioners
(GPs) whose practices included members of the target
communities. Interim analysis of the findings from each
phase of the research was used to inform data collection
in the subsequent phase. All study procedures were ap-
proved by the Research Ethics Committee at Queen Mary,
University of London (No. QMREC2012/02).
Phase 1: Key informant interviews
We interviewed people working in key roles within
hepatitis treatment services and advocacy in the target
Sweeney et al. BMC Health Services Research  (2015) 15:97 Page 2 of 17
communities, in order to gather their views on how so-
cial and cultural influences might affect hepatitis screen-
ing and treatment [27]. All provided written informed
consent for participation and audio recording. We inter-
viewed staff members from community health organisa-
tions (n = 5), healthcare interpreters within hospital and
primary care services (n = 5), specialist hepatitis nurses
(n = 3), consultant hepatologists (n = 2), an assistant
Imam (n = 1) and a sexual health doctor (n = 1). Re-
cruitment occurred through community organisations,
invitations to people already known to the research
team, and snowball sampling. A semi-structured inter-
view guide (see Appendix 1) was used, but the interview
also provided space for discussion of topics raised spon-
taneously by the interviewee. All interviews were con-
ducted and transcribed verbatim by LS.
Phase 2: Focus groups
We explored the health beliefs, knowledge and folk
models of hepatitis B and C in community members and
their responses to a proposal for hepatitis screening and
treatment in primary care. Recruitment was facilitated by
community health organisations, who had established
trust and support within the local immigrant communities
that we hoped to reach. These organisations approached
community members about focus group participation and
written and verbal information about the study was pro-
vided in the preferred language of participants. No diffi-
culties with the recruitment process were reported to the
research team, though we acknowledge that some sensitiv-
ities may not have been readily shared. Two pilot focus
groups were initially conducted with the Pakistani com-
munity in east London. Focus groups were then held for
Pakistani, Chinese, Somali and Polish-speaking Roma
communities. We conducted separate male and female
groups for each of these communities, in case any poten-
tial discussion of the sexual transmission of viral hepatitis
caused discomfort and unease for participants within
mixed-gender groups. However, we were advised by the
organisation for African communities that mixed-gender
groups would be appropriate for the French and English-
speaking members of their communities, so we organised
the groups in accordance with their advice.
A bilingual staff member from the relevant community
organisation facilitated each focus group. They had pre-
vious experience with facilitating community discussion
or support groups, and were briefed in advance regard-
ing the nature and purpose of the research. Facilitators
also assisted with the development of the focus group
format and question schedule.
Each focus group participant provided written consent
for audio recording of the discussions and for anon-
ymised data to be used for research purposes. Partici-
pants completed a brief demographic questionnaire.
Focus groups were attended by LS or JO (gender
matched to participants), who sat in the corner of the
room with a second translator, so that they could note
any issues that needed further probing or clarification
later in the discussion.
A focus group discussion guide (see Appendix 2) was
developed from our review of the literature and refined
following the outcomes of the pilot focus groups.
Discussion began with broad questions about health
problems within the community and knowledge and
awareness of hepatitis B and C. Facilitators then pro-
vided participants with brief verbal information about
these conditions. To gauge perceived acceptability of
hepatitis screening and treatment in primary care, struc-
tured vignettes were used to invite participants to re-
spond to the hypothetical story of a gender-matched
character from their community who had received a let-
ter from his/her GP inviting him/her for hepatitis B and
C screening (which reflected the design of the ‘HepFree’
study intervention). The use of fictional vignettes in
qualitative research allows participant beliefs regarding
appropriate action in the situational context to be ex-
plored in greater depth, and is also a less threatening
method of introducing a potentially sensitive research
topic [28,29], as fears or stigma can be projected onto
the fictional character rather than owned as personal.
Following each focus group, LS worked with the bilin-
gual facilitators to translate and transcribe the audio re-
cordings. Word-for-word translation of qualitative
research data can obscure the communication of mean-
ing in participants’ contributions [30]. Through working
jointly with the facilitators to transcribe the recordings,
any confusion concerning the explanation of meaning in
words and phrases used by the participants were ad-
dressed in the process of producing the transcript. Co-
transcription also facilitated initial data interpretation, as
it involved discussion of culturally specific issues and the
meaning in participants’ accounts.
Phase 3: General practitioner interviews
Individual telephone interviews were conducted with six
GPs (four based in London and two in Bradford) to ex-
plore experiences with hepatitis screening and treatment
with patients from immigrant communities, and per-
ceived acceptability of the ‘HepFree’ intervention in pri-
mary care. The London-based GPs worked in areas with
high social disadvantage and ethnic-diversity. One was
based in a practice with a large patient base from
Pakistan and one worked in a practice that specifically
worked with recent immigrants, asylum seekers and ref-
ugees. The two Bradford-based GPs worked in inner city
Bradford. Both worked in practices with a high propor-
tion of South Asian (mostly Pakistani) patients, and one
also worked in an additional practice for asylum seekers
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and refugees, mostly from African countries. A semi-
structured topic guide (Appendix 3) was used for the GP
interviews, but the interview provided space for discus-
sion of topics raised spontaneously by informants, who
gave verbal consent for audio recording. All interviews
were conducted and transcribed verbatim by LS.
Data analysis
Data were managed in accordance with the data protec-
tion policy of Queen Mary University of London (avail-
able from authors). The datasets from each phase of the
research were analysed separately, using the Framework
method [31,32]. In an initial orientation and familiarisa-
tion stage, LS reviewed the transcripts in depth, noting
key ideas and emerging issues that arose from the ori-
ginal research questions and the issues raised by the par-
ticipants. TG independently reviewed a sub-set of
transcripts. The initial concepts were organised into a
preliminary thematic framework on an Excel spread-
sheet. We then went through each transcript in turn,
adding columns to the spreadsheet to accommodate new
themes and shaping the draft framework into analytic
categories. The spreadsheet format allowed charting of
the range and nature of perspectives on each theme.
Emerging findings were presented for discussion at team
meetings, which facilitated further interpretation and re-
finement of themes and concepts. Themes from the key
informants, focus group and GP datasets were then
compared and contrasted. Ongoing analysis and inter-
pretation were also informed by theoretical perspectives
from the literature concerning attitudes to health screen-
ing and access to healthcare services for vulnerable
groups [33,34]. Community health and advocacy organi-
sations were invited to provide comments and feedback
on study findings.
Results
Characteristics of sample
Table 1 shows demographic characteristics of the key in-
formants and general practitioners. Table 2 summarises
the demographics of the focus group participants. Partici-
pants were not asked directly whether they had previously
been tested for, or received a diagnosis for hepatitis B or
C. During five of the focus group discussions, at least one
participant voluntarily informed the group that they had
hepatitis B or C, and in most of the focus group discus-
sions at least one participant referred to a family member
or friend who had experienced hepatitis infection.
The key informant, focus group and GP data were
highly convergent, each source tending to affirm and ex-
tend findings from the others. The main themes identified
were: limited awareness and knowledge of hepatitis B and
C (especially lack of awareness about the asymptomatic
nature of chronic infection and confusion about modes of
transmission); mixed views on the nature and level of
stigma associated with these conditions; (broadly) positive
attitudes to screening and treatment in principle, but nu-
merous practical barriers to uptake of this in practice; and
(for some) lack of confidence in the primary care sector.
Capacity issues in primary care were identified from GP
interviews. We elaborate on these themes in turn below.
Limited awareness and knowledge of hepatitis B and C
Key informants and general practitioners perceived that
there was very limited knowledge about hepatitis B and C
(in terms of the nature of the viruses, their transmission
and outcomes) within the target immigrant communities.
Key informants for the Chinese and Pakistani communi-
ties felt that people with an affected family member were
aware of these conditions, but specific knowledge was be-
lieved to be low. Key informants for the Eastern European
(including Roma) and African communities perceived very
little awareness and understanding about hepatitis B and
C within these communities.
Most focus group participants had heard of hepatitis B
and C, but many felt that they did not know much about
these illnesses, and that they were rarely discussed un-
less a family member was affected.
“Yes we know about the hepatitis B, C. But we only
know the name, we don’t know how it is, how it works,
we don’t know.” (Female, Roma community group)
Key informants and general practitioners felt that many
people were unaware of the serious outcomes of untreated
Table 1 Demographics of key informants and general
practitioners
Key informants General practitioners
Total no. of participants 17 6
Mean (SD) age (years) 47 (9) 52 (14)
Sex:
Male 4 5
Female 13 1
Ethnicity:
African 4 1
Asian/Asian British
- Chinese 3 -
- Pakistani 2 -
- Indian - 1
White
- British 3 3
- Eastern European 4 -
Not stated 1 1
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chronic hepatitis infection, unless family members had ex-
perienced liver cancer or other critical outcomes. Some
focus group participants identified that untreated hepatitis
B and C infection can lead to cancer or death, but others
contrasted hepatitis with “more serious” illnesses such as
cancer, diabetes, HIV and TB. Key informants pointed out
that hepatitis had not been promoted in health education
efforts to the same extent as other illnesses or infectious
diseases, with the result that it did not typically feature in
community discourses about serious illness.
“Right now, not many people are relating to hepatitis.
What we know in the African communities it is HIV, it
is TB, diabetes, hypertension- those are the things that
are out there.” (Key informant for African
communities, Sexual health doctor)
Key informants who worked in hepatitis treatment ser-
vices observed that patients from immigrant communi-
ties were often unaware whether their diagnosis was for
hepatitis B or C. Focus group participants also indicated
uncertainty and confusion about the differences between
the types of viral hepatitis. Many believed that hepatitis
C was a more harmful infection than hepatitis B, due to
an (implied) assumption that the letters represented in-
creasing severity.
“They say A is OK, B is in the middle and C you’re
going to judgement day [death].” (Male, Somali
community group)
Several participants also speculated that the different
types of hepatitis emerge chronologically, (i.e. B becomes
C if left untreated).
Confusion about mode of transmission and risk of
becoming infected
Key informants felt that people in the target communi-
ties knew little about how hepatitis B and C are trans-
mitted, or the high risk of infection in their own
community. They also pointed out that immigrants who
had lived in the UK for many years would be unlikely to
perceive themselves to be at risk due to a lack of aware-
ness that hepatitis can be a chronic, asymptomatic infec-
tion that they may have acquired at a younger age.
[Described a typical exchange when approaching
people for testing at community event] “Oh there’s
Table 2 Demographics of focus group participants
Community Chinese community,
London (2 groups)
Pakistani communities,
London and Bradford
(4 groups)
Roma communities,
London (2 groups)
Somali community,
London (2 groups)
African communities,
London (2 groups)
Total no.
participants
12 35 15 16 17
Mean (SD) age
(years)
41 (6) 49 (15) 35 (12) 45 (6) 53 (10)
Sex:
- Male 6 18 8 8 4
- Female 6 17 7 8 13
Generation
immigrant
- First
generation
12 24 15 16 16
- Years in UK:
Mean (SD)
10 (10) 30 (13) 10 (4) 13 (5) 12 (4)
- Second
generation
- 11 - - 1
Highest level
of education
- No formal
education
- 3 - 1 -
- Primary level
or below
2 3 1 3 1
- Secondary
level
6 5 14 7 11
- University level 2 3 - 5 1
- Not stated 2 21 - - 2
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nothing wrong with us”. I go, “How do you know?
You’re Asian aren’t you? You’re Pakistani Muslim
aren’t you?”…“…We’ve not done anything wrong, we
don’t do drugs”. I go, “You’ve had your head shaved as
a baby, you’ve been circumcised as a baby, how can
you say you’ve not got the virus?” (Key informant for
Pakistani community, community support worker)
Some focus group participants correctly mentioned at
least one of the main routes of transmission for hepatitis
B and C, such as through non-sterilised injection prac-
tices, sexual transmission, and transmission from
mother to child, and in every focus group contact with
infected blood was mentioned as a risk factor. However,
participants also suggested that hepatitis B or C can be
caused by dirty water, poor sanitation, seafood, fried or
buttery foods, alcohol use, and mosquitoes, and trans-
mitted via saliva or through sharing food, cups or
utensils.
“I don’t believe that you can get it that easily, like flu.
Because then we would all have it…It has to be
through contact of blood or injections.”
“…If I drink from a cup and it’s not washed properly
and the next person drinks it then that’s how it
spreads.” (Female participants, Somali community
group)
Our data suggested that different communities held
different explanations for how hepatitis is transmitted
within the community. In the Chinese groups, much
discussion focused on the shared eating practices of
Chinese people; family members and friends typically
used their own cooking utensils when diagnosed with
hepatitis B. Roma groups talked of transmission through
surgery or blood transfusions and referred to people
they knew who had been infected in this way. Our
informant and focus group data suggested that African
communities tend to focus on the sexual transmission
of viral hepatitis, which may be due to awareness within
these communities that many individuals in sub-
Saharan Africa are co-infected with HIV and hepatitis
B/C (although the association between transmission
modes of these infections is limited in African
countries) [35].
No symptoms, no problem
The words used to refer to hepatitis in the languages of
the target communities directly translated to mean ‘jaun-
dice’ or ‘yellow’, which was a source of confusion and
appeared to engender a strong perceived association be-
tween hepatitis B/C and visible jaundice. Many focus
group participants believed that yellow skin, eyes and
nails would be apparent in a person with hepatitis B or
C and that this was how the person would know that
they had the infection. Others (perhaps confusing hepa-
titis B/C with hepatitis A) believed that acute physical
symptoms, such as vomiting, fever and headaches, would
accompany hepatitis B or C infection.
Some focus group participants, particularly those who
had personal or family experience of chronic viral hepa-
titis, were aware that the condition could present with
tiredness and a general sense of feeling unwell. Whilst a
minority of participants were aware that chronic hepa-
titis B or C infection may be asymptomatic, many par-
ticipants expressed surprise and concern when they
were informed that hepatitis B and C infection may not
be accompanied by symptoms, but can still go on to
produce serious complications.
Key informants and focus group participants felt that
people typically relied upon the presence of symptoms
as an indication of infection and cue to action, and
therefore, those in their communities who were not ex-
periencing symptoms of ill health would be unlikely to
respond to a hepatitis screening invitation.
“If they think that it’s something that’s not worth their
while, you know, ‘I’ve got nothing wrong with me, I
don’t have any liver pains, I’m not jaundiced, why
would I have hepatitis B? I’m not going to go for
screening’.” (Key informant for Chinese community,
community support worker)
The asymptomatic nature of chronic hepatitis
infection was also indicated to reduce its perceived
severity. Key informants who worked in hepatitis
treatment services reported that lack of symptoms often
compromised uptake and adherence to treatment, when
patients could not see the purpose of being monitored
or taking medication if they felt well. Nevertheless, both
key informants and focus group participants generally
felt that most people diagnosed with hepatitis B or C
within the target communities would be keen to receive
treatment, particularly once they became aware of the
seriousness of the condition.
Mixed views on stigma
Our data indicated mixed opinions on the nature and
extent of stigma associated with hepatitis B and C
infection. Some key informants believed that negative
attitudes were more likely in those who associated
hepatitis with “dirty” practices like sexual transmission
or injection drug use, perhaps in the absence of
knowledge about other modes of transmission. Stigma
was reported to cause reluctance amongst some
hepatitis patients to disclose their diagnosis. Stigma
was also attributed to lack of public awareness and
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knowledge about hepatitis B or C, as people felt un-
comfortable telling others about a diagnosis which they
could not explain. A few informants also indicated that
a diagnosis might carry particular stigma for young
people, because it could influence opportunities for
marriage.
At the same time, many key informants, focus group
participants and general practitioners perceived signifi-
cantly less stigma for hepatitis than for cancer, mental
health problems and (in particular) HIV. Key informants
and general practitioners reported that people from im-
migrant communities were more open to discussing and
testing for hepatitis than for HIV or other sexually trans-
mitted infections, and were typically less distressed by a
hepatitis diagnosis, which was often viewed “like any
other illness”.
While most focus group participants believed that
people within their communities would provide support
to family members or friends following a hepatitis diag-
nosis, some participants also referred to fear of infection
and, hence, anxiety around social practices such as eat-
ing together, sharing utensils or coming into contact
with blood or saliva. Key informants indicated that a
hepatitis diagnosis can be particularly difficult for immi-
grants living in the UK without family support, as they
often live in temporary accommodation with lots of
other housemates, who may be unsupportive due to fear
of infection.
“..one gentleman, his things were packed because he
accidently left in the kitchen his medications and the
housemates Googled what he was using these for and
they found out that it’s hepatitis drugs and then he
came in from work and his things were out in the
suitcase.” (Key informant for Eastern European
communities, Hospital interpreter)
In contrast, a few participants felt that there was less
fear within their communities about interaction with a
person with hepatitis compared to a person with HIV or
TB, because the latter infections were perceived to cause
more serious consequences.
Attitudes to screening
Key informants, focus group participants and general
practitioners stressed individual differences and variation
between people in any community in their responses to
screening invitations. Many people were expected to ig-
nore a hepatitis screening invitation letter if they had
not previously come across the condition within their
family or community, or if they felt well. General practi-
tioners spoke about reluctance of some immigrant pa-
tients to attend for health checks or vaccinations,
necessitating repeated reminders through letters, tele-
phone and text messages.
There was disagreement on whether a hepatitis screen-
ing invitation should state that a particular community
is at increased risk of hepatitis, since this may be inter-
preted as associating the entire community with poverty,
being “dirty”, or being from a less civilised or advanced
country. An invitation for screening may cause some
people to be suspicious about why they had been se-
lected, including perceived targeting by immigration ser-
vices. Key informants and focus group participants from
African communities referred to a suspicion within these
communities that blood testing may be used to secretly
test for other conditions, or to deliberately infect people
with an illness. In this context, any mention of research
in the invitation to screening was thought likely to in-
crease suspicion and reduce uptake. Some participants
also suggested that people in their communities might
fear the next steps (such as invasive scans or other un-
pleasant tests) in the hepatitis testing process, or the side
effects of treatment if they tested positive.
Key informants and focus group participants consid-
ered that attending optional preventive health services
might not be a priority for many immigrants who were
already experiencing significant social and economic
pressures. Screening might lead to a person being diag-
nosed with a serious illness when they did not have the
emotional reserves or social support to cope with this.
“I got a smear test invite for women who are over 40.
After I got my invite I said to myself, “What if they
diagnose me with this (word meaning ‘horrible
thing’)?” So I did not go. And until now I never went.
So I’m very scared, it’s very hard for me to go.”
(Female, Somali community group)
Advice from peers was perceived to be an important
influence on decision-making about health issues. If a per-
son’s family and friends did not understand hepatitis and
its implications, they might discourage attendance for
screening. While some key informants, focus group partic-
ipants and general practitioners believed that a letter from
a doctor would be taken seriously and prompt attendance
for screening, others felt that in addition to this, more
widespread communication about hepatitis and hepatitis
screening through community networks and religious or-
ganisations would help increase uptake, as would primary
care staff raising the idea of hepatitis screening when pa-
tients attended for other reasons. General practitioners
had observed that people were generally willing to be
tested for hepatitis when their doctor had discussed the
reasons for screening with them in advance.
Most focus group participants (who may have been a
particularly health-conscious sample) said that they
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themselves would accept the offer of hepatitis screening,
and that they would advise their family and friends to re-
spond similarly. These participants viewed screening as a
socially responsible activity and a good opportunity to
protect oneself from illness and gain peace of mind about
one’s health. They suggested that a hepatitis screening
programme ought to be framed in this way to their com-
munity. However, a number of participants felt that they
and others from their community would ‘ignore’ or ‘avoid’
a screening invitation letter, particularly if it was not com-
pulsory. Taking up a screening invitation was an active
choice and involved effort; participants felt that if the per-
son was feeling well and did not perceive a need to be
tested, this effort may not be considered worthwhile. Par-
ticipants also believed that people may ignore the first
letter, expecting to be contacted a second time if the
screening was important.
“It depends on the person, some will make an
appointment straight away and some, like me, will
avoid it and become lazy.” (Female, Pakistani
community group)
Age and gender were potential influences on response
to screening invitation. Younger people were perceived
as more proactive about their health, more open to test-
ing for sexually transmitted infections, and to have
greater access to health information. But they were also
viewed as more likely to perceive themselves as healthy
and not in need of screening. Women were generally
seen as more concerned about health and more likely to
be in regular contact with their general practitioner
(with the exception of women from traditional Pakistani
families), while men generally did not want to make con-
tact with health services unless they were feeling very ill.
Barriers to uptake of a primary care based service
Key informants felt that while a screening and treatment
programme offered through NHS primary care would be
popular and convenient for many people, it would not
reach at-risk immigrants who lacked legal status in the
UK and/or were not registered with a general practice.
Focus group participants spoke about the difficulty getting
appointments in general practice services and delays be-
tween making an appointment and seeing the doctor, per-
haps reflecting the significant pressures on the primary
care sector. The long working hours and limited employ-
ment rights (e.g. lack of formal contracts, no sick pay) of
many people from immigrant communities were also
viewed as a significant barrier to accessing healthcare
services–and hence to uptake of screening and treatment.
“Especially those in the catering section, they work
more than 10 hours a day, six days a week. Even if
they are not feeling well they don’t have time to see a
doctor. If this person has hepatitis B and there are no
symptoms, even if he knows he has it, he doesn’t want
to go for a check-up.” (Male, Chinese community
group)
Limited English proficiency was also identified as a
significant barrier to accessing screening and treatment
for hepatitis. Primary care services were perceived to
vary widely in their provision of interpreting services.
Patients from the Pakistani communities were often reg-
istered with a general practitioner who spoke their lan-
guage; though because practices had recently become
larger in size, with a wider patient base from new immi-
grant groups, this could not always be accommodated.
Many immigrant patients appeared to rely on family
members or friends to interpret letters from healthcare
services and to communicate on their behalf at medical
appointments– an arrangement that can prove difficult
if the consultation involves sensitive topics or specialist
medical terminology, and which may put pressure on
the bilingual relative to take time off work to act as an
unpaid translator. Language and communication diffi-
culties prompted some immigrant patients to consult
with private general practitioners or traditional medicine
practitioners who spoke their language. The provision of
screening invitation letters in the languages of the target
communities and the provision of interpreting services
were widely considered to be essential prerequisites for a
successful hepatitis screening and treatment service:
“I had a friend, I told him that I had hepatitis B. I
told him to go for the test because he used to come to
my place for meals. He told me ‘How can I go for a
test? I don’t speak English’. He said he’s worried about
going because he can’t speak English.” (Female,
Chinese community group)
Key informants for the Chinese, Pakistani and Roma
communities stressed that a considerable proportion of
people from these communities had difficulty reading
written information provided in their spoken languages;
therefore, information about hepatitis and hepatitis
screening would also need to be provided in alternative
formats.
Acceptability of primary care based screening and treat-
ment services was seen to depend on the quality of the re-
lationship between the patient and the general practitioner.
Key informants and focus group participants believed that
such a model would appeal particularly to people who
had a longstanding, trusting relationship with a regular
general practitioner who understood their health his-
tory. Such a situation was by no means universal
amongst immigrant communities. New immigrants in
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particular were sometimes perplexed by primary care
services and surprised and disappointed not to receive
a referral to secondary care (which would have been
standard in their country of origin) when they pre-
sented to their general practitioner. Some general prac-
titioners were perceived to “rush” appointments and
not provide patients with the opportunity to talk
through symptoms and explain their concerns, leading
to loss of patient confidence:
“I cut off the relationship with my GP because I never
had the chance to express myself about my pain. So
now when I’m not feeling well I go to the hospital
straight away.” (Male, French-speaking African group)
Women in the Roma, Somali and Pakistani communi-
ties tended to feel more comfortable attending a female
general practitioner. Participants in the Roma and So-
mali community groups described consulting with pri-
vate doctors in order to have sufficient time for
explanations and information about illnesses. Informants
for the Eastern European communities indicated that
many people from these communities travel back to
their home countries for healthcare, for easier access to
medical tests and consultations, and because they had
greater confidence in the standard of care received
(sometimes equated with number of tests ordered or re-
ferrals to specialists). Key informants and general practi-
tioners observed that many immigrant patients prefer to
consult with specialist doctors for the treatment of illness
and thus may feel “fobbed off” by primary care based treat-
ment. Several focus group participants expressed concern
that if hepatitis was a serious illness, a general practitioner
may not have sufficient knowledge and expertise to sup-
port patients undergoing hepatitis treatment.
Capacity issues in general practice
General practitioners who worked in practices specific-
ally for asylum-seekers and refugees reported that all pa-
tients who had moved to the UK from regions with high
hepatitis B or C prevalence were typically screened in ac-
cordance with Health Protection Agency guidelines.
Those in other practices reported that their antenatal
patients from immigrant communities were routinely
screened for hepatitis B and that contact tracing for fam-
ily members of those who test positive was attempted.
Screening for hepatitis C was perceived as more of a
concern for patients who inject drugs, or when a patient
showed abnormal liver function test results.
Some general practitioners expressed concern that estab-
lishing a new, independent hepatitis screening programme
would be labour intensive and perhaps not the most effect-
ive use of limited practice resources at a time of increasing
demands on the primary care sector. The prevailing policy
of ‘care closer to home’ had meant that general practi-
tioners were being asked to take on numerous tasks
traditionally undertaken by hospital teams and hence
were feeling under significant strain. While the con-
venience for patients of a primary care based hepatitis
screening service was acknowledged, practices with
limited physical space and without additional support
services (such as phlebotomy), were felt unlikely to be
capable of supporting such a service. Key informants and
general practitioners highlighted the heavy time demands
and challenges involved in following up immigrant pa-
tients for screening and treatment appointments, partly
because of frequent changes of address within this popula-
tion and high patient turnover.
Our sample of general practitioners reported that fol-
lowing a hepatitis diagnosis, they discuss the meaning of
the diagnosis with the patient, including the implications
for transmission and the process of referral to specialist
hepatitis treatment services, and some played a role in
the treatment journey of their patients after referral to
specialist clinics (for example, providing information and
emotional support, particularly when the patient felt un-
well or distressed from the side-effects of hepatitis treat-
ment). However, our sample was probably self-selecting
for interest in hepatitis. Our key informant data sug-
gested that many patients receive little information or
support from their general practitioner following their
diagnosis and only begin to learn about hepatitis when
they attend specialist treatment services.
One general practitioner pointed out that hospital-based
hepatitis clinics could provide multidisciplinary support to
patients, including access to psychological support for pa-
tients undergoing treatment. Others suggested that gen-
eral practitioners may lack knowledge and confidence in
overseeing the active treatment of chronic viral hepatitis,
or may not have the appointment capacity to monitor
treatment. Some general practitioners expressed their
frustration at the insufficient consideration of the long-
term resource needs for an intervention to be continued
following a positive pilot phase, even when positively eval-
uated and ‘evidence-based’.
Discussion
Summary of main findings
This qualitative study, the first of its kind in the UK, has
surfaced a number of factors that must be taken account
of when planning a comprehensive screening and treat-
ment service for hepatitis B and C in high-risk immi-
grant communities. In particular, the level of awareness
and knowledge of these conditions in immigrant com-
munities was generally low, and at best variable; with
misunderstandings about modes of transmission, limited
awareness of the asymptomatic nature of chronic infec-
tion, and underestimation of the seriousness of hepatitis
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B and C infection. While a primary care based service
for screening and treatment would be convenient for pa-
tients, language and accessibility barriers may remain an
issue for immigrant communities. Our findings also
raised questions both about patients’ confidence in gen-
eral practitioners and the capacity of the primary care
sector to deliver such a service. Table 3 provides a sum-
mary of the research findings, alongside their implica-
tions for the design of screening and treatment services.
Links to previous literature
Our findings confirm previous research on the confusion
regarding the differences between the types of viral hepa-
titis [36], along with a folk model that the hepatitis A, B
and C viruses are interconnected and progressive in their
severity [22,37]. Hepatitis A is the most common form of
viral hepatitis and has moderate to very high prevalence in
the countries of origin of the communities in the current
study [38], which may be why risk factors for hepatitis A
have been incorporated into the folk model for hepatitis B
and C. We also confirm findings in previous studies
[22,37] that hepatitis is linked in folk models to ‘yellow’ or
‘jaundice’ and that many people are unaware that chronic
hepatitis infection can be asymptomatic [36]. Similar to
previous research [22,24,39], we found that hepatitis B
and C are largely not viewed as serious, life-threatening ill-
nesses within the target communities.
While we found some awareness of the key routes of
transmission for hepatitis B and C, many people at high
risk (by virtue of their country of origin) may be unlikely
to perceive a need for hepatitis screening if they are un-
aware that hepatitis can be a chronic, asymptomatic in-
fection that they may have acquired at a younger age.
Absence of symptoms has been associated in previous
studies with reluctance to attend for screening, [40] in-
cluding for hepatitis [20]. Previous researchers have
linked low public awareness of chronic viral hepatitis to
the limited attention the condition has received in health
education and media campaigns [36,41], and shown (as
we did) that most awareness and knowledge of the con-
dition comes from personal or family experience of the
illness [42,43].
Our study found variation in the level of stigma associ-
ated with chronic viral hepatitis, with the greatest stigma
attached to perceived associations between hepatitis and
socially unacceptable behaviours, such as sexual promis-
cuity and injecting drug use; which may be reinforced by
health promotion literature concerning the key modes of
hepatitis B/C transmission in the white British popula-
tion. Research by others has also shown that whilst
stigma surrounding hepatitis is often lower than that for
HIV [23,44,45], where stigma is high there is reluctance
amongst patients to disclose a hepatitis diagnosis to
others [46].
We found that immigrant communities in the UK may
be fearful of day-to-day interaction (especially meals) with
people who have hepatitis B or C infection, due to misper-
ceptions regarding the transmission of these viruses. Per-
ceived contagion risk has historically been associated with
social and physical avoidance of individuals with disease
[47] and fear of contagion has previously been shown to
contribute to the stigma surrounding hepatitis B and C
[43,45,46,48,49].
Doctor recommendation for hepatitis screening has
previously been identified as strongly associated with
screening uptake in immigrant communities [50-52]. We
identified that there may be sensitivity amongst immi-
grant communities about being targeted ‘en masse’ for
hepatitis screening, in contrast to a previous study of
perceived acceptability of tuberculosis screening for im-
migrants that found little sensitivity to targeted screen-
ing in those who had been tested [53]. It is possible that
people may find offence in a letter which points out that
their community is at increased risk of an infectious dis-
ease, but welcome a detailed verbal explanation from
their GP about the risks in their country of origin.
Health inequalities for minority ethnic populations are
strongly associated with socioeconomic disadvantage;
[54] though utilisation of healthcare services, including
screening uptake, can vary by ethnicity [55,56]. Our find-
ings corroborate previous work showing that structural
and practical barriers (notably the stresses and con-
straints of socio-economic disadvantage, and low health
and system literacy) have an important role in access to
optional screening services [33]. Uptake of national
screening programmes is generally lower amongst
people from socially disadvantaged areas [57]. The more
rigid working patterns involved in manual employment
have previously been associated with greater perceived
difficulty in accessing healthcare, particularly for op-
tional, preventive health services [21,58]. These are likely
to affect various immigrant communities in different
ways, given the very different employment patterns by
ethnic group [59].
Disadvantaged groups are more likely to have a nega-
tive outlook on future events and to experience in-
creased feelings of threat, which means that they are
more likely to expect testing procedures to be unpleas-
ant and uncomfortable, and to worry about the out-
comes of screening, and the physical and psychological
consequences of a diagnosis [33]. As in our study, fear
of acquiring a frightening diagnosis has been found to
be an important barrier to screening uptake in minority
ethnic communities [60].
Language and literacy were consistently identified as im-
portant influences on the willingness and ability of immi-
grants to engage with hepatitis screening and treatment
programmes. Language and communication difficulties
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are amongst the strongest influences on help-seeking be-
haviour, access to healthcare, and experiences of services
for minority ethnic communities [55,61,62], and a bigger
barrier to screening engagement than attitudes to screen-
ing [63]. Reliance on family members to translate can con-
strain availability to attend services and compromise the
accuracy and quality of information exchanged [64],
though the use of trusted family members can in some cir-
cumstances improve access for those who perceive the of-
ficial interpreting services as unsympathetic or alienating
[65], or who cannot otherwise access interpretive services.
Our finding that uptake of a primary care based screen-
ing and treatment service is likely to depend on the
strength and quality of the GP-patient relationship (which
in turn depends on continuity of care and the perceived
time available for dealing with patients’ own priorities)
resonates strongly with previous research on the key de-
terminants of trust and confidence in GP care [66-69],
particularly for minority ethnic patients [70]. Trust, satis-
faction and continuity of care have been found to influ-
ence receptiveness to doctor recommendations about
preventive care and screening intentions [71,72].
Table 3 Summary of main research findings and implications for design of screening and treatment services
Main findings Implications
Limited knowledge and confusion about hepatitis B and C in at-risk
communities
Community-based information campaigns
• Participants reported a lack of awareness of the asymptomatic nature
of chronic infection with hepatitis B/C within at-risk communities. Many
immigrants may not consider themselves at risk from hepatitis B/C if
they have lived in the UK for many years.
• Information is needed regarding the asymptomatic nature of chronic
infection and the potentially serious outcomes of untreated infection.
• Chronic viral hepatitis does not typically feature in community
discourses about serious illness, because many people are unaware of
the outcomes from chronic infection, because those diagnosed often
have no symptoms of illness, and because hepatitis has not received the
same health promotion/ media coverage as other illnesses. People are
typically more worried about illnesses such as cancer, diabetes and HIV.
• Information is needed to improve understanding of how hepatitis B
and C may be acquired in high-risk regions and to amend
misunderstandings about transmission.
• We found uncertainty and confusion about the differences between the
types of viral hepatitis within at-risk communities. Many people indicated
a belief that hepatitis C was more serious than hepatitis B.
• Collaborative working is needed between health educators and
community groups, faith organisations, etc. to communicate verbal
information about hepatitis and screening.
• There was some awareness within the focus groups about the main
transmission routes of hepatitis B/C, but misperceptions were also
reported that indicated confusion with the transmission of hepatitis A
and other causes of liver disease.
• High levels of stigma were generally not perceived for hepatitis, but
stigma may arise due to perceived association with socially unacceptable
behaviours, and due to fear of infection.
Barriers to hepatitis screening and treatment for immigrant patients Service implications
• PRACTICAL BARRIERS • Information about screening and treatment provision ought to be
provided in the languages of the communities that are targeted for
screening. Language support services will be needed to assist patients
with making and attending appointments.
- Language and communication difficulties are a major barrier for
immigrant communities in accessing primary care.
• Flexible/extended opening hours may be needed for hepatitis
screening and treatment services.
- The long working hours and limited working rights (e.g. no sick pay) of
many immigrants were viewed as a significant barrier to accessing
screening and treatment services.
• People need to be fully informed in advance about what is involved in
the testing and treatment process, and that treatment is free of charge.
- Screening invitation letters may be ignored, particularly if the person
does not understand hepatitis or does not perceive a need for
screening. • GPs or other primary care staff may need to verbally explain the
reasons for hepatitis screening to the patient, rather than relying on
screening invitation letters.• PSYCHOLOGICAL BARRIERS
• Collaborative working with community groups to provide support to
patients during treatment.- Screening uptake may be prevented by fear of diagnosis, fear of the
testing process involved and fear of potential side effects from
treatment. • Patients may need to be provided with reassurance and confidence
that they will receive effective treatment for hepatitis through primary
care services.
• Problems with trust and confidence in primary care amongst immigrant
communities may reduce uptake of screening and treatment.
General practitioner concerns Policy implications
• Workload implications and concerns about sustainability may discourage
general practice participation in the delivery of hepatitis screening and
treatment services.
• Ongoing consultation with primary care services regarding support
needs for delivery of hepatitis screening and treatment.
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Our findings indicate that some people within the tar-
get communities may have limited confidence in a gen-
eral practice-based service to manage chronic viral
hepatitis, if they are aware of its seriousness. The more
serious an illness is perceived to be, the more likely a pa-
tient will want a referral to a specialist and the less likely
they will be to trust their GP’s management of the illness
[73]. Recent immigrants from a country with a poor or
absent primary health care sector may be particularly
distrustful of GPs and associate ‘quality’ care with hos-
pital referral, extensive investigations and prescribed
medication [66,67].
This study indicated that even GPs with an interest
in hepatitis management were concerned about their
capacity to support a screening and treatment service.
Previous studies have revealed similar concerns
amongst GPs about both the resource burden of trans-
ferring services from secondary to primary care [73],
and the time and resource challenges to being involved
with the delivery of healthcare interventions for re-
search [74-76].
Strengths and limitations of the study
By exploring how hepatitis B and C are viewed in high-risk
immigrant communities and the perceived acceptability of
a primary-care model of screening and treatment, this
study makes an important contribution to the develop-
ment of strategies to test and treat population groups at
greatest risk of chronic viral hepatitis. The validity of our
findings is strengthened by our multi-phased approach to
data collection, including the perspectives of members of
communities at increased risk, key people working within
those communities, specialist healthcare professionals
working in hepatitis treatment services, and general practi-
tioners. Previous studies of knowledge and attitudes to-
wards viral hepatitis in immigrant communities have
focused on either hepatitis B or C, and have typically lim-
ited their data collection to one particular immigrant
group (mostly Asian communities in North America). To
gain a more comprehensive picture, the current study
looked at understanding of both conditions across several
high-risk communities and is the first study to include per-
spectives on hepatitis B and C amongst Roma, Somali and
other African communities. We have illustrated that
many of the barriers to hepatitis screening (including
low knowledge about hepatitis B and C) are shared
across the target communities, a similar finding to pre-
vious research on barriers to cancer screening in mi-
nority ethnic groups [57]. Whilst we found differences in
understanding and folk models of viral hepatitis between
the community groups, this study was specifically oriented
to informing the design of a standardised intervention to
be rolled out in a multi-ethnic community locally (and, we
anticipate, nationally). Furthermore, our sample was too
small to draw confident conclusions about inter-group dif-
ferences. Future research targeted at particular communi-
ties could further explore culturally-specific influences on
hepatitis screening behaviour.
Focus group participants were recruited through
community organisations which may have caused se-
lection bias [23]. Those recruited were generally
known to the organisations, thus were more likely to
be people with relatively high health literacy who ac-
tively engage in community health events. Through
our research design we aimed to circumvent the po-
tential selection bias of the focus group sample. By
interviewing key informants who worked in a range of
different roles within the communities under study, we
gathered an insight into the spectrum of attitudes to
hepatitis and the range of healthcare barriers faced by
members of these communities, including those less
likely to participate in research. Furthermore, the use of
vignette techniques in the focus groups encouraged partic-
ipants to speak about factors affecting people in their
wider community which may influence engagement with
hepatitis screening, in addition to their own personal in-
tentions. However, future research ought to widen data
collection within each immigrant community to include
the views of community members who are perhaps more
isolated from health and community support services, and
whose perspectives and experiences may differ from those
that are represented in our focus group data. Snowball
sampling could perhaps be used, where people known to
organisations could be asked to inform other friends and
relatives who are not linked in with services about the
research.
There was a wide age range in our focus groups. We
did not stratify by age, which may have affected the
findings. For example, younger Roma women contrib-
uted relatively little to group discussions, perhaps be-
cause of a cultural tendency to defer to more senior
members. Our data suggested that younger people
within immigrant communities were perceived to have
greater access to health information and to be more
open to testing for sexually transmitted infections than
older ones, but may be less likely to perceive a need for
screening if they feel healthy. Future research could ex-
plore these issues in greater depth using stratification
by age or generation.
A key limitation of the current study is that we cannot
extrapolate participants’ responses to a hypothetical
screening invitation, since intentions to attend screening
are typically higher than actual attendance [77]. Given
the well-described gap between what people say they
would do and what they actually do, future research
should explore the ‘real world’ experiences and health
needs of immigrant groups who are offered screening
and treatment for hepatitis B and C.
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There were also limitations with our GP data collec-
tion. A small number of GPs were willing to be inter-
viewed; some of those who did not participate indicated
that they already had too many constraints on their time.
The representativeness of our GP informant sample
therefore requires consideration, thought the current
study does not claim that our findings regarding the cap-
acity issues that may affect a primary care-based inter-
vention for chronic viral hepatitis are representative of
all GP practices that may be approached to deliver such
an intervention. Further qualitative research at a later
point in the ‘HepFree’ study with primary care practices
who do participate in delivering the intervention may un-
cover different GP perspectives on negotiating the time
and resource demands of research. There is also likely to
have been a selection bias in the sample of general practi-
tioners interviewed for this study, who reported that they
actively support their patients undergoing hepatitis treat-
ment. Our key informant data provided a wider perspective
on GP engagement with chronic viral hepatitis services,
which included those who gave less priority to the condi-
tion. We also acknowledge that asking GPs about a single
question covering their approach to hepatitis B and C may
have reduced our potential to explore differences in their
management of these two different diseases.
Conclusions
This paper has identified a range of issues likely to affect
engagement with hepatitis screening and treatment in
primary care for immigrant communities. The concept
of ‘candidacy’ proposed by Dixon-Woods et al. [55] as a
means of understanding access to healthcare services by
vulnerable groups is a useful framework for interpreting
these findings. They outline how “people’s eligibility for
medical attention and intervention is jointly negotiated
between individuals and health services” (pp.42). In the
case of a screening invitation, candidacy, or eligibility for
screening is proposed by the healthcare provider. In
order for a person to then present themselves for screen-
ing, they must accept that the provider statement of
their eligibility is consistent with their own perceptions
of eligibility, and that the invitation is worth acting upon
in terms of the resources and efforts that are needed in
order to engage with the screening service.
With regards to hepatitis screening, response to a
screening invitation from the GP will firstly depend on
whether the patient perceives themselves to be at risk
of chronic hepatitis infection, which is likely to be in-
fluenced by their awareness and understanding of the
condition. Secondly, their response will depend on the
challenges that they may face in mobilising the psycho-
logical and practical resources to navigate the screening
and treatment process. While a community-based
model of screening and treatment in primary care was
largely viewed as a positive development in the current
study, numerous challenges were outlined which immi-
grant communities may face in engaging with such a
model; including fear of diagnosis, language and com-
munication difficulties, work demands, and issues with
trust and confidence in GP care. The magnitude of
these challenges is likely to vary both within and across
communities; for example, engaging with healthcare
services may be particularly difficult for immigrants
who are living in the UK without family support, or
without people to communicate on their behalf with
healthcare services.
Implications for screening and treatment services
The ‘HepFree’ study (funded by the National Institute for
Health Research) will examine the clinical and cost-
effectiveness of a large programme of hepatitis screening
and treatment in NHS primary care services, with the
aim to provide evidence-based recommendations to the
National Screening Committee. The research presented
in this paper has identified contextual factors relating to
expected acceptability and engagement with such a
programme in high-risk immigrant communities, thus
highlighting key issues which are likely to affect the de-
sign, implementation and outcomes of the ‘HepFree’
study. The implications of our research finding for the
delivery of hepatitis screening and treatment services in
primary care are summarised in Table 3.
Our findings indicate that information campaigns are
needed to address limited understanding of chronic viral
hepatitis within at-risk immigrant communities. In particu-
lar, information is needed regarding how hepatitis B and C
are transmitted in high-risk regions, the asymptomatic na-
ture of chronic infection and the outcomes of untreated
chronic infection. At the same time, information cam-
paigns must take care not to cause alarm or fear about
these infections, which may discourage screening attend-
ance through fear of diagnosis, and may exacerbate any
stigma for people with a diagnosis of hepatitis B or C.
Information that amends misunderstandings about hepa-
titis B and C transmission may also reduce potential
stigma. Information about hepatitis and encouragement
for screening may need to be communicated verbally
through community and religious organisations, and de-
tailed explanations from GPs or other practice staff, in
addition to initial screening invitation letters. Verbal ex-
planations and support for screening may reduce patient
fears surrounding the testing process and the potential
outcomes of a diagnosis.
To reduce language and communication barriers to
hepatitis screening and treatment, services will need to
provided information (written and verbal) in the lan-
guages of the communities that are targeted, and the
availability of interpretive services to assist people with
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making and attending appointments must also be con-
sidered. Services may need to be flexible in terms of their
opening hours to accommodate the inflexible working
hours of many immigrant patients. If community-based
treatment for chronic viral hepatitis is to be provided in
primary care services, patients may need to be provided
with confidence and reassurance that effective treat-
ment can be provided in primary care. Primary care
practices will also need to receive ongoing support and
consultation in relation to their capacity for delivering
such a model.
Appendix 1: Key informant interview questions
General
 What do you think are the key health issues
affecting the X community in London?
 What do you think are the key issues that affect
this community in terms of accessing GPs and
health services?
Hepatitis
 From your experience, what do people think about
hepatitis B and C within this community?
 How do they think hepatitis B and C are
transmitted?
 Do you think people within the X community think
that they are at risk for hepatitis?
 How do people hear about hepatitis within this
community?
– Who do people talk to about hepatitis?
Screening
 What do you think are the reasons why people
from the community get tested for hepatitis?
– What do you think are the reasons why people
do not get tested?
– How do you think things could be improved to
support people to get tested for hepatitis?
Explain planned intervention of GP-based screening and
treatment for chronic viral hepatitis
 How do you think people will react to a hepatitis
screening invitation letter from their GP?
 What kind of challenges do you think there might
be in recruiting people for testing in this way?
 Do you think there are any sensitive matters we will
need to pay attention to in sending these letters out
to the X community?
 Are there any cultural factors which are specific
to the X community that you think may have a
role in whether or not people get tested for viral
hepatitis?
Treatment
 Do people in the community tend to engage with
treatment for hepatitis if diagnosed?
 Why do you think some people who test positive
for hepatitis may not seek treatment?
 Do people seek care and treatment from any other
sources (alternative medicine)?
 How do you think people from the community
could be best supported to get treatment for
hepatitis?
 What kind of effects does a hepatitis diagnosis have
for people in the X community?
Appendix 2: Focus group topic guide/key
discussion questions
 What do you think are important health issues for
the X community living in London?
 Do you know of any infections or diseases that
affect the liver?
 Can anyone explain what hepatitis B and C are?
 Has anyone ever talked about hepatitis with family
or friends?
 Does anyone know how people get hepatitis B or C?
 Do you think the X community is at risk for
hepatitis?
 How would someone know if they had hepatitis B or C?
– Information piece about hepatitis B and C
presented verbally to group
– Vignette presented verbally to group: “This
[silhouette image] is a woman, Mrs. N-, from the
X community living in London. She has just
received a letter from her GP inviting her to be
tested for viral hepatitis.”
 What will she be thinking when she gets the letter?
 Why do you think she might not want to get tested?
– What might she be worried about?
– What would make it difficult for her to go for
testing?
 Why do you think she might decide to go for testing?
 If she asked her family or friends for advice about
whether to go for the test, what do you think they
would say?
 If your friend came to you for advice about whether
to go for the test what would you say?
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 Who could she go to for more information about
hepatitis?
 If she knew how serious viral hepatitis is do you
think she would be tested for it?
 Do you think there would be any differences
between a man and a woman about whether they
would want to get a test for hepatitis?
 If we wanted to encourage lots of people from the X
community in London like Mrs. N- to come for
testing, what should we say in an invitation to them?
Vignette continues: “Mrs. N- has been tested and the
doctor has told her that she has chronic viral hepatitis”
 What would she think when she discovers this?
 What do you think her family and friends will think
about this? What will other people in the community
think?
 Do you think it would affect her life in any way?
 Where do you think she would go for treatment?
Vignette continues: “Mrs. N-’s GP has told her that she
can receive treatment for her hepatitis at the GP service”
 Do you think she would want to receive treatment
for hepatitis from her GP service? (Why/why not?)
 Is there anything that might make it difficult for
her to get treatment?
Appendix 3: General practitioner interview
questions
 Who do you typically test for hepatitis B and C at
your practice?
 Can you recall particular situations in which the
issue of testing for hepatitis has arisen with your
patients, and how this was discussed?
 How is a positive result for hepatitis managed in
your practice?
 Do you discuss the treatment plan, etc.?
 What do patients typically need from you following
a hepatitis diagnosis?
 Do you think many GPs offer hepatitis testing to
their patients from ethnic minority or immigrant
communities? (Why/Why not?)
 What kind of barriers do you think there are for
GPs in offering hepatitis tests to their patients from
ethnic minority or immigrant communities?
Explain planned intervention of general practice-based
screening and treatment for chronic viral hepatitis
 What kind of reaction do you think your patients
would have to a hepatitis screening invitation letter?
 What do you think about providing treatment for
hepatitis at GP practices?
 What kind of benefits/ problems do you think there
might be with this kind of intervention?
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